Stockreport

OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient Visit

OS Therapies Incorporated  (OSTX) 
PDF Company to ring Closing Bell at NYSE on Thursday, October 3, 2024Interviews scheduled with Fintech.TV and Schwab Network NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE [Read more]